|
|
||||||||
Review |
Gianfranco Donelli, PhD, Department of Technologies and Health Istituto, Superiore di Sanità, Rome, Italy
Emilio Guaglianone, BSc, Department of Technologies and Health, Istituto Superiore di Sanità, Rome, Italy
Roberta Di Rosa, MD, Chair of Clinical Immunology, 2nd Faculty of Medicine, University of Rome "La Sapienza", Rome, Italy
Fausto Fiocca, MD, Department of General Surgery "P. Stefanini", University of Rome "La Sapienza", Rome, Italy
Antonio Basoli, MD, Department of General Surgery "P. Stefanini", University of Rome "La Sapienza", Rome, Italy
Reprint Requests: Gianfranco Donelli, PhD, Department of Technologies and Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy, Tel: 39-06-49902228, Fax: 39-06-49387141, Email: donelli{at}iss.it
Endoscopic biliary stenting is today the most common palliative treatment for patients suffering from obstructive jaundice associated with malignant hepatobiliary tumors or benign strictures. However, recurrent jaundice, with or without cholangitis, is a major complication of a biliary endoprosthesis insertion. Thus, stent removal and replacement with a new one frequently occurs as a consequence of device blockage caused by microbial biofilm growth and biliary sludge accumulation in the lumen. Factors and mechanisms involved in plastic stent clogging arising from epidemiological, clinical and experimental data, as well as the possible strategies to prevent biliary stent failure, will be reviewed and discussed.
Key Words: Biliary stent Cholangitis Endoscopic insertion Microbial biofilm Prevention Stent occlusion
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |